Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudia Provenzano

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Computational and Structural Biotechnology Journal|December 28, 2020
Design of novel small molecule base-pair recognizers of toxic CUG RNA transcripts characteristics of DM1Raul Ondono, Ángel Lirio, Carlos Elvira, et al.
Molecular Therapy. Nucleic Acids|September 2, 2025
circARHGAP10 as a candidate biomarker and therapeutic target in myotonic dystrophy type 1Denisa Baci, Spyros Tastsoglou, Claudia Provenzano, et al.
Molecular Therapy. Nucleic Acids|January 3, 2022
Time-controlled and muscle-specific CRISPR/Cas9-mediated deletion of CTG-repeat expansion in the <i>DMPK</i> geneBeatrice Cardinali, Claudia Provenzano, Mariapaola Izzo, et al.
Clinical and Translational Medicine|February 16, 2025
Muscle-specific gene editing improves molecular and phenotypic defects in a mouse model of myotonic dystrophy type 1Mariapaola Izzo, Jonathan Battistini, Elisabetta Golini, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Computational and Structural Biotechnology Journal|December 28, 2020
Design of novel small molecule base-pair recognizers of toxic CUG RNA transcripts characteristics of DM1Raul Ondono, Ángel Lirio, Carlos Elvira, et al.
Molecular Therapy. Nucleic Acids|September 2, 2025
circARHGAP10 as a candidate biomarker and therapeutic target in myotonic dystrophy type 1Denisa Baci, Spyros Tastsoglou, Claudia Provenzano, et al.
Molecular Therapy. Nucleic Acids|January 3, 2022
Time-controlled and muscle-specific CRISPR/Cas9-mediated deletion of CTG-repeat expansion in the <i>DMPK</i> geneBeatrice Cardinali, Claudia Provenzano, Mariapaola Izzo, et al.
Clinical and Translational Medicine|February 16, 2025
Muscle-specific gene editing improves molecular and phenotypic defects in a mouse model of myotonic dystrophy type 1Mariapaola Izzo, Jonathan Battistini, Elisabetta Golini, et al.
Pageof 2